Q&A: The “Secret Sauce” Of Sofinnova’s New AI-Based Investment Platform
The venture group has debuted Sofinova.AI, a software platform capable of viewing a potential investment in much more detail than a human.
You may also be interested in...
Sofinnova Partners has played an important role in defining the medtech investment space for the past 50 years, helping bring to market a plethora of life-saving technologies, even when they appear, initially, to be risky.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Less than a month after it sold off its reproductive health assets, Invitae has filed for bankruptcy. That will not come as a surprise to anyone following the company.